Part I | Chapter 5 106 References 1. Lagendijk JJW, Raaymakers BW, Raaijmakers AJE, Overweg J, Brown KJ, Kerkhof EM, et al. MRI/linac integration. Radiother Oncol 2008;86:25–9. 2. Winkel D, Bol GH, Kroon PS, van Asselen B, Hackett SS, Werensteijn-Honingh AM, et al. Adaptive radiotherapy: The Elekta Unity MR-linac concept. Clin Transl Radiat Oncol 2019;18:54–9. 3. Fischer-Valuck BW, Henke L, Green O, Kashani R, Acharya S, Bradley JD, et al. Two-and-a-half-year clinical experience with the world’s first magnetic resonance image guided radiation therapy system. Adv Radiat Oncol 2017;2:485–93. 4. de Muinck Keizer DM, Kerkmeijer LGW, Willigenburg T, van Lier ALHMW, den Hartogh MD, van der Voort van Zyp JRN, et al. Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions. Radiother Oncol 2020;151:88– 94. 5. Nichol AM, Brock KK, Lockwood GA, Moseley DJ, Rosewall T, Warde PR, et al. A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol 2007;67:48–56. 6. Wen N, Glide-Hurst C, Nurushev T, Xing L, Kim J, Zhong H, et al. Evaluation of the deformation and corresponding dosimetric implications in prostate cancer treatment. Phys Med Biol 2012;57:5361–79. 7. Mayyas E, Kim J, Kumar S, Liu C, Wen N, Movsas B, et al. A novel approach for evaluation of prostate deformation and associated dosimetric implications in IGRT of the prostate. Med Phys 2014;41. 8. Miralbell R, Roberts SA, Zubizarreta E, Hendry JH. Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) Gy. Int J Radiat Oncol 2012;82:e17– 24. 9. Fowler J, Chappell R, Ritter M. Is α/β for prostate tumors really low? Int J Radiat Oncol 2001;50:1021– 31. 10. Dasu A, Toma-Dasu I. Prostate alpha/beta revisited -- an analysis of clinical results from 14 168 patients. Acta Oncol 2012;51:963–74. 11. Kontaxis C, de Muinck Keizer DM, Kerkmeijer LGW, Willigenburg T, den Hartogh MD, van der Voort van Zyp JRN, et al. Delivered dose quantification in prostate radiotherapy using online 3D cine imaging and treatment log files on a combined 1.5T magnetic resonance imaging and linear accelerator system. Phys Imaging Radiat Oncol 2020;15. 12. de Muinck Keizer DM, Kerkmeijer LGW, Maspero M, Andreychenko A, van der Voort van Zyp JRN, van den Berg CAT, et al. Soft-tissue prostate intrafraction motion tracking in 3D cine-MR for MR-guided radiotherapy. Phys Med Biol 2019;64:235008. 13. Menten MJ, Mohajer JK, Nilawar R, Bertholet J, Dunlop A, Pathmanathan AU, et al. Automatic reconstruction of the delivered dose of the day using MR-linac treatment log files and online MR imaging. Radiother Oncol 2020;145:88–94. 14. Pathmanathan AU, van As NJ, Kerkmeijer LGW, Christodouleas J, Lawton CAF, Vesprini D, et al. Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A “Game Changer” for Prostate Treatment? Int J Radiat Oncol Biol Phys 2018;100:361– 73. 15. Bosma LS, Zachiu C, Ries M, Senneville BD De, Raaymakers BW. Quantitative investigation of dose accumulation errors from intra-fraction motion in MRgRT for prostate cancer Phys Med Biol 2021; 66 065002 16. Lagerwaard F, Bohoudi O, Tetar S, Admiraal MA, Rosario TS. Combined Inter- and Intrafractional Plan Adaptation Using Fraction Partitioning in Magnetic Resonance-guided Radiotherapy Delivery Case Presentation. Cureus 2018;10:1–9. 17. de Muinck Keizer DM, van der Voort van Zyp JRN, de Groot-van Breugel EN, Raaymakers BW, Lagendijk JJW, de Boer HCJ. On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy. Phys Imaging Radiat Oncol 2021;19:90–5. 18. Bol GH, Kotte ANTJ, van der Heide UA, Lagendijk JJW. Simultaneous multi-modality ROI delineation in clinical practice. Comput Methods Programs Biomed 2009;96:133–40. 19. van Herk M, Remeijer P, Rasch C, Lebesque J V. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol 2000;47:1121–35. 20. de Muinck Keizer DM, Willigenburg T, van der Voort van Zyp JRN, Raaymakers BW, Lagendijk JJW, de Boer JCJ. Seminal vesicle intrafraction motion during the delivery of radiotherapy sessions on a 1.5T MR-Linac. Radiother Oncol 2021;162:162-169. 21. Kontaxis C, Bol GH, Lagendijk JJW, Raaymakers BW. A new methodology for inter-and intrafraction plan adaptation for the MR-linac. Phys Med & Biol 2015;60:7485.
RkJQdWJsaXNoZXIy MTk4NDMw